The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

2010/05/21 by P. Lassen, Pernille Lassen · 3 citations
Medicine · #Cervical Cancer and HPV Research #Cholangiocarcinoma and Gallbladder Cancer Studies #Head and Neck Cancer Studies

paper · doi:10.1016/j.radonc.2010.04.022

openalex publication_date 2010/05/21 · crossref created 2010/05/21 · crossref issued 2010/06/01 · crossref published 2010/06/01 · crossref published-print 2010/06/01 · crossref deposited 2021/10/28 · openalex created_date 2025/10/10 · crossref indexed 2026/04/30 · openalex updated_date 2026/07/28

Citations

• Trends in head and neck cancer incidence in relation to smoking prevalence
• Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer
• Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
• A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
• Papillomaviruses and cancer: from basic studies to clinical application
• Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
• Oral Human Papillomavirus Infection in Adults Is Associated with Sexual Behavior and HIV Serostatus
• High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
• Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
• Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

Cited by

• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
• Patient preferences for oropharyngeal cancer treatment de‐escalation
• HPV-positive oropharyngeal cancer [wikipedia]